FDA’s NDI Guidance: What You Need to Know

The FDA released the draft New Dietary Ingedient (NDI) guidance on July 5, 2011. AHPA's educational seminar, featuring presentations from AHPA President Michael McGuffin, General Counsel Tony Young, former FDA insider Bill Frankos, Ph.D., and a panel of legal experts with experience filing over 30 NDI notifications, assists with understanding the key elements of the guidance and how it will impact businesses in the supplement industry. Discussion topics include historical background, FDA's rationale during the development of the guidance, general business impact, GRAS status and NDI, and the potential impact to specific categories such as probiotics, nanotechnology, and others.

• Jim Prochnow, Esq, Greenberg Traurig
• Tony Young, Esq, Kleinfeld, Kaplan & Becker
• Ashish Talati, Esq, Amin Talati
• Paul Rubin, Esq, Patton Boggs
• Alan Feldstein, Esq, Collins, McDonald & Gann
• Michael McGuffin, AHPA

• Presentation files from the webinar
• Audio file